Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 11:30 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 673–696 of 1,807 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Implanted Device Clear all

Conditions: Amputation Neuroma, Amputation
Interventions: a bipolar percutaneous intramuscular electromyography electrode; Device
Lead sponsor: University of Michigan; Other
Eligibility: 22 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2029
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Glaucoma
Interventions: Baerveldt Device surgical Procedure; Procedure
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 5
States / cities: Sacramento, California • Miami, Florida • Baltimore, Maryland + 2 more

Conditions: Urologic Diseases, Male Urogenital Diseases, Penile Diseases, Corpus Callosum Malformation, Corpora Cavernosa; Inflammation, Trauma Injury
Interventions: Autologous tissue engineered corpora; Biological
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Painful Diabetic Neuropathy (PDN), Diabetic Neuropathy, Neuropathic Pain, Chronic Pain
Interventions: BurstDR Spinal Cord Stimulation; Device
Lead sponsor: TriCity Research Center; Industry
Eligibility: 19 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Grand Island, Nebraska

Conditions: Osteoarthritis, Knee, Knee Osteoarthritis
Interventions: ConforMIS iUni, iDuo, or iTotal (CR); Device
Lead sponsor: Restor3D; Industry
Eligibility: 18 Years and older
Enrollment: 950 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boynton Beach, Florida

Conditions: Acute Ischemic Stroke
Interventions: Active Stimulation, Sham Stimulation; Device
Lead sponsor: BrainsGate; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 327 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Chattanooga, Tennessee

Conditions: Type 2 Diabetes, Obesity
Interventions: rechargeable TANTALUS II; Device
Lead sponsor: MetaCure (USA), Inc.; Industry
Eligibility: 21 Years to 70 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 2
States / cities: Los Angeles, California • San Antonio, Texas

Conditions: Left Atrial Appendage Absent
Interventions: AtriClip; Device
Lead sponsor: AtriCure, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 156 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 11
States / cities: Indianapolis, Indiana • St Louis, Missouri • Albany, New York + 6 more

Conditions: Stroke, Spinal Cord Injuries and Disorders, Hemiparesis After Stroke
Interventions: Spinal Cord Stimulator (Medtronic Inceptiv™ System), Physical Therapy; Device · Other
Lead sponsor: Marco Capogrosso; Other
Eligibility: 22 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Glaucoma, Open-Angle, Glaucoma
Interventions: iStent Inject Implantation; Device
Lead sponsor: Glaukos Corporation; Industry
Eligibility: 22 Years and older
Enrollment: 358 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 3
States / cities: Phoenix, Arizona • Torrance, California • Dallas, Texas

Conditions: Symptomatic Cartilage Defects of the Femoral Condyle
Interventions: BioCart™II, Microfracture; Biological · Procedure
Lead sponsor: ProChon Biotech Ltd; Industry
Eligibility: 16 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 5
States / cities: Tucson, Arizona • Savannah, Georgia • Baltimore, Maryland + 2 more

Conditions: Complete DiGeorge Anomaly, DiGeorge Syndrome, DiGeorge Anomaly, Complete DiGeorge Syndrome
Interventions: Cultured Thymus Tissue; Biological
Lead sponsor: Sumitomo Pharma Switzerland GmbH; Industry
Eligibility: Not listed
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Amputation; Traumatic, Leg, Lower
Interventions: OPRA; Device
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 22 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 2
States / cities: Bethesda, Maryland • Philadelphia, Pennsylvania

Conditions: Alcohol Use Disorder
Interventions: DBS; Device
Lead sponsor: Khaled Moussawi; Other
Eligibility: 21 Years to 75 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Aortic Aneurysm, Thoracoabdominal, Aortic Aneurysm, Thoracic, Aortic Dissection, Thoracoabdominal
Interventions: Endovascular treatment of Thoracoabdominal Aortic Aneurysm, Endovascular treatment of Aortic Arch Aneurysms; Device
Lead sponsor: Darren Schneider, M.D.; Other
Eligibility: 18 Years and older
Enrollment: 520 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2033
U.S. locations: 2
States / cities: New York, New York • Philadelphia, Pennsylvania

Conditions: Parkinson Disease
Interventions: Neural recordings and stimulation; Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 40 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Bilateral Hearing Loss for Causes Other Than Tumors
Interventions: Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI); Device
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Contraception
Interventions: ENG implant, oral ulipristal acetate; Device · Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Spinal Cord Injuries
Interventions: Tests of sympathetic inhibition, Tests of above level sympathetic activation, Testing of below level sympathetic activation, Epidural stimulation, Transcutaneous stimulation; Diagnostic Test · Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 50 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Femoro Acetabular Impingement
Interventions: LoopLoc Arm, Control Arm; Device
Lead sponsor: American Hip Institute; Other
Eligibility: 18 Years to 60 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Des Plaines, Illinois

Conditions: Cerebral Aneurysms
Interventions: Contour Neurovascular System Treatment Attempt; Device
Lead sponsor: Cerus Endovascular, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 9
States / cities: Park Ridge, Illinois • Kansas City, Kansas • Buffalo, New York + 5 more

Conditions: Restless Leg Syndrome (RLS), Spinal Cord Stimulation (SCS)
Interventions: Spinal Cord Stimulation; Device
Lead sponsor: Marshall Holland; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2034
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Pain
Interventions: neurostimulation system; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 4,800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2035
U.S. locations: 67
States / cities: Phoenix, Arizona • Tucson, Arizona • Campbell, California + 60 more

Conditions: Diabetes, End Stage Renal Disease
Interventions: EchoMark/EchoSure, Standard of Care; Device · Procedure
Lead sponsor: Sonavex, Inc.; Industry
Eligibility: 18 Years to 84 Years
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 23
States / cities: Dothan, Alabama • Phoenix, Arizona • Tucson, Arizona + 19 more

Search by objective public record fields.

Short-term Implanted Electrodes Following Regenerative Peripheral Nerve Surgery for Improving Prosthetic Limb Control Signals

Baerveldt Plate Area Comparison (BPAC)

Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora

Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy

A Retrospective Study to Evaluate the ConforMIS iUni, iDuo & iTotal® KRS

Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window (ImpACT-24A)

A Prospective, Clinical Trial of the TANTALUS® System in Treatment of Obese to Morbidly Obese Patients

VCLIP Post-Market Study, Long-term Follow-up on LAA Exclusion Using AtriClip

Spinal Cord Stimulation Combined With Physical Therapy in Post-Stroke Upper-Limb Motor Hemiparesis

iStent Inject New Enrollment Post-Approval Study

Comparison of BioCart™II With Microfracture for Treatment of Cartilage Defects of the Femoral Condyle

Thymus Transplantation Safety-Efficacy

Transtibial Osseointegration

Deep Brain Stimulation for Alcohol Use Disorder

Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts

Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation

Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects

Ovarian Function With ENG Implant and UPA Use

Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury

Knotless Implants As an Alternative for Capsular Closure in Primary Hip Arthroscopy: a Prospective, Multi-Center Study

Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)

Neuromodulation to Overcome Severe Restless Legs Syndrome

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial